Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Caldesmon controls stress fiber force-balance through dynamic cross-linking of myosin II and actin-tropomyosin filaments. | Nat Commun | 2022 | 36229430 | PubTator, text mining | PubMed |
| Case Report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient. | Front Oncol | 2022 | 36226049 | PubTator, text mining | PubMed |
| Ex vivo exposures to arsenite and its methylated trivalent metabolites alter gene transcription in mouse sperm cells. | Toxicol Appl Pharmacol | 2022 | 36209798 | PubTator, text mining | PubMed |
| Multiple roles of neuronal extracellular vesicles in neurological disorders. | Front Cell Neurosci | 2022 | 36204449 | PubTator, text mining | PubMed |
| AZIN1 RNA editing alters protein interactions, leading to nuclear translocation and worse outcomes in prostate cancer. | Exp Mol Med | 2022 | 36202978 | PubTator, text mining | PubMed |
| RNA-seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy. | Microcirculation | 2022 | 36198058 | PubTator, text mining | PubMed |
| Recent advances in inhibition of porcine reproductive and respiratory syndrome virus through targeting CD163. | Front Microbiol | 2022 | 36187992 | PubTator, text mining | PubMed |
| Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics. | Front Endocrinol (Lausanne) | 2022 | 36187110 | PubTator, text mining | PubMed |
| Comprehensive characterization of ubiquitinome of human colorectal cancer and identification of potential survival-related ubiquitination. | J Transl Med | 2022 | 36184622 | PubTator, text mining | PubMed |
| Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo. | Cancer Drug Resist | 2022 | 36176747 | PubTator, text mining | PubMed |
| Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia. | BMC Cancer | 2022 | 36175877 | PubTator, text mining | PubMed |
| Systematic identification of intron retention associated variants from massive publicly available transcriptome sequencing data. | Nat Commun | 2022 | 36175409 | PubTator, text mining | PubMed |
| Long Noncoding RNA TPRG1-AS1 Suppresses Migration of Vascular Smooth Muscle Cells and Attenuates Atherogenesis via Interacting With MYH9 Protein. | Arterioscler Thromb Vasc Biol | 2022 | 36172865 | PubTator, text mining | PubMed |
| Oviductal Glycoprotein 1 Promotes Hypertension by Inducing Vascular Remodeling Through an Interaction With MYH9. | Circulation | 2022 | 36172862 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling. | EMBO Mol Med | 2022 | 36161772 | PubTator, text mining | PubMed |
| CD163-Expressing Porcine Macrophages Support NADC30-like and NADC34-like PRRSV Infections. | Viruses | 2022 | 36146862 | PubTator, text mining | PubMed |
| Juvenile Membranous Nephropathy Developed after Human Papillomavirus (HPV) Vaccination. | Vaccines (Basel) | 2022 | 36146521 | PubTator, text mining | PubMed |
| A Human Stem Cell-Derived Neurosensory-Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation. | Biomedicines | 2022 | 36140168 | PubTator, text mining | PubMed |
| MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway. | Cells | 2022 | 36139430 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=43